Purdue Pharma bankruptcy shielding Sackler family heads to Supreme Court Purdue Pharma, the maker of OxyContin, filed for Chapter 11 bankruptcy protection in September 2019 after it faced scores of lawsuits related to the opioid crisis. Dec 4, 2023...
Purdue Pharma is close to a new bankruptcy settlement with its owners, members of the wealthy Sackler family, and state and local governments that have filed lawsuits alleging that its painkiller OxyContin spurred a deadly opioid-addiction crisis in the U.S., … ...
Sign up and get the latest news in your inbox. Enter your email address BioPharma,Legal Reports: Sackler family offers to relinquish reins of Purdue Pharma to resolve opioid suits Citing anonymous sources familiar with the matter, news outlets reported that the family would pay $3 billion toward...
October 22, 2020 / 9:44 AM EDT / CBS News Purdue Pharma, the maker of the highly addictive Oxycontin opioid drug, pleaded guilty to felony criminal charges today, settling with the U.S. government for more than $8.3 billion. The settlement, which resolved criminal charges and civil liabil...
Avrio Health L.P., a subsidiary of Purdue Pharma L.P., announced the launch of SlowMag® Mg Calm+Sleep, a dietary supplement with Magnesium Citrate and Melatonin.
Privacy Policy (the “Privacy Policy”), which is part of the Purdue Pharma L.P. Terms and Conditions, before you access, download, or otherwise use any of our websites, related other parties’ websites, mobile applications, or any electronic service (collectively, the “Service”). This ...
Purdue Pharma, the company that makes OxyContin, the powerful prescription painkiller that experts say helped touch off anopioidepidemic, willpleadguilty to three federal criminal charges as part of a settlement of more than $8 billion, Justice Department officials announced Wednesday. ...
Purdue Pharma has announced the acquisition from VM Pharma LLC of VM-902A, a first-in-class, allosteric selective tropomyosin receptor kinase A (TrkA) inhibitor, as well as the backup compounds and associated intellectual property for the potential treatment of chronic pain. TrkA is a...
NEW YORK (Reuters) -Purdue Pharma is close to a new bankruptcy settlement with its owners, members of the wealthy Sackler family, and state and local governments that have filed lawsuits alleging that its painkiller OxyContin spurred a deadly opioid-addiction crisis in the U.S., a...
Stay up-to-date with breaking news and top stories on Purdue Pharma LP. In-depth analysis, industry insights and expert opinion